Kalvista Pharmaceuticals, Inc. - KALV

Latest data: 12/20/2024 10:22:22 PM
EDGAR CIK 0001348911

Buy Breakdown

Total $0

Sell Breakdown

Total $3,554,042

Monthly Totals

Transaction Filed Name Type Shares @ Price Value Balance change Ownership
02/14/2024
02/16/2024
CEO
CEO Director
Sell
-58,356 @ $15.01
($875,882.71)
181,676 (-24.31%) Direct
02/14/2024
02/16/2024
CHIEF SCIENTIFIC OFFICER
Officer
Sell
-28,171 @ $15.01
($422,826.99)
71,657 (-28.22%) Direct
02/14/2024
02/16/2024
CFO, CBO
CFO
Sell
-40,855 @ $15.01
($613,204.95)
159,088 (-20.43%) Direct
02/14/2024
02/16/2024
CHIEF DEVELOPMENT OFFICER
Officer
Sell
-39,886 @ $15.01
($598,660.94)
66,160 (-37.61%) Direct
02/01/2024
10b5-1
02/05/2024
CEO
CEO Director
Sell
-10,000 @ $16.22
($162,198.44)
117,532 (-7.84%) Direct
01/11/2024
10b5-1
01/12/2024
Chief Scientific Officer
Officer
Sell
-22,679 @ $13.03
($295,514.17)
39,828 (-36.28%) Direct
01/09/2024
10b5-1
01/10/2024
Chief Scientific Officer
Officer
Sell
-100 @ $13.00
($1,300.00)
62,507 (-0.16%) Direct
01/08/2024
10b5-1
01/10/2024
Chief Scientific Officer
Officer
Sell
-17,221 @ $13.01
($224,000.44)
62,607 (-21.57%) Direct
12/27/2023
10b5-1
12/28/2023
CEO
CEO Director
Sell
-30,000 @ $12.02
($360,453.00)
127,532 (-19.04%) Direct